Politiparty
Politiparty

118th Congress Health

H.R. 4702: Securing Gene Synthesis Act

Introduced

  1. Introduced (completed)Jul 18, 2023
  2. Passed House (not reached)
  3. Passed Senate (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in House, Jul 18, 2023

This bill requires the Department of Health and Human Services to issue regulations to prevent the misuse of de novo gene synthesis products (i.e., manufactured gene products), including screening protocols for providers of these products. Federal agencies and entities that receive federal funds may only purchase such products from providers that comply with the screening protocols.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

2

Who scored on this bill

0 points earned

No member has earned points from it yet.

See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Anna Eshoo

History

  1. Jul 18, 2023Introduced in the House by Anna Eshoo.
Show the full action history (3 actions)
  1. Jul 21, 2023Referred to the Subcommittee on Health.
  2. Jul 18, 2023Introduced in House
  3. Jul 18, 2023Referred to the House Committee on Energy and Commerce.